UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 505

Sortiert nach

Membrane transport of cobalamin

Vitamins and hormones, 2022, Vol.119, p.121-148

2022

Link zum Volltext

Verfügbarkeit prüfen

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

Gynecologic oncology, 2017-06, Vol.145 (3), p.453-461

2017

Link zum Volltext

Verfügbarkeit prüfen

Design and Application of Project-Based Learning Methodologies for Small Groups Within Computer Fundamentals Subjects

IEEE access, 2019, Vol.7, p.12456-12466

2019

Link zum Volltext

Verfügbarkeit prüfen

P618: SECOND‐GENERATION CD19 TARGETING TRI‐SPECIFIC KILLER ENGAGER DRIVES ROBUST NK CELL FUNCTION AGAINST B CELL MALIGNANCIES

HemaSphere, 2022-06, Vol.6, p.517-518

2022

Link zum Volltext

Verfügbarkeit prüfen

Transcutaneous oxygen tension measurements following peripheral transluminal angioplasty procedure has more specificity and sensitivity than ankle brachial index

British journal of radiology, 2015-02, Vol.88 (1046), p.20140571-20140571

2015

Link zum Volltext

Verfügbarkeit prüfen

Cobalamin decyanation by the membrane transporter BtuM

Structure (London), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.19-19

2017

Link zum Volltext

Verfügbarkeit prüfen

Using Genetic Engineering to Improve the Bispecific Antibody Platform for MDS Therapy

Leukemia research, 2017, Vol.55, p.S126-S126

2017

Link zum Volltext

Verfügbarkeit prüfen

Development of Emotional Skills through Interdisciplinary Practices Integrated into a University Curriculum

Education research international, 2017-01, Vol.2017 (1)

2017

Link zum Volltext

Verfügbarkeit prüfen

CONCEPTUALIZACIÓN DE ENTIDADES TERMINOLÓGICAS EN UNA SUBONTOLOGÍA DE DERECHO PENAL: ANÁLISIS DEL CONCEPTO SUPERORDINADO +DRUG_00 EN FUNGRAMKB

Revista de lingüística y lenguas aplicadas, 2020-07, Vol.15 (1), p.15-25

2020

Link zum Volltext

Verfügbarkeit prüfen

ARID5B regulates metabolic programming in human adaptive NK cells

The Journal of experimental medicine, 2018-09, Vol.215 (9), p.2379-2395

2018

Link zum Volltext

Verfügbarkeit prüfen

965MO GTB-3550 tri-specific killer engager safely activates and delivers IL-15 to NK cells, but not T-cells, in immune suppressed patients with advanced myeloid malignancies, a novel paradigm exportable to solid tumors expressing Her2 or B7H3

Annals of oncology, 2021-09, Vol.32, p.S834-S834

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Molecular therapy, 2021-12, Vol.29 (12), p.3410-3421

2021

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal or subcutaneously administered IL-15 superagonist (N-803) increases NK cell cytotoxicity in ovarian cancer

Gynecologic oncology, 2020-10, Vol.159, p.41-42

2020

Link zum Volltext

Verfügbarkeit prüfen

755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cells

Annals of oncology, 2022-09, Vol.33, p.S889

2022

Link zum Volltext

Verfügbarkeit prüfen

17P Driving NK cell immunotherapy against NSCLC, in the context of hypoxia, using tri-specific engagers

Annals of oncology, 2022-03, Vol.33, p.S10

2022

Link zum Volltext

Verfügbarkeit prüfen

A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses

The Journal of biological chemistry, 2003-12, Vol.278 (51), p.51613-51621

2003

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-induced memory-like natural killer cells demonstrate enhanced effector functions against ovarian cancer

Gynecologic oncology, 2018-06, Vol.149, p.51-51

2018

Link zum Volltext

Verfügbarkeit prüfen

126P Novel B7-H3 targeting dual nanobody NK cell engagers display robust activity against a broad spectrum of solid and hematologic malignancies

Annals of oncology, 2021-12, Vol.32, p.S1433

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of Ruxolitinib combined with Nivolumab in patients relapsed/refractory Hodgkin lymphoma after failure of check‐point inhibitor (CPI)

Hematological oncology, 2023-06, Vol.41 (S2), p.582-582

2023

Link zum Volltext

Verfügbarkeit prüfen

Responses after Allogeneic NK Cell Therapy for Lymphoma: correlative analysis revealed impact of host monocytes and robust T cells tumor trafficking

Hematological oncology, 2023-06, Vol.41 (S2), p.518-519

2023

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus and systemic inflammation is associated with worse outcomes in serous ovarian cancer patients

Gynecologic oncology, 2019-06, Vol.154, p.51-51

2019

Link zum Volltext

Verfügbarkeit prüfen

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

Blood advances, 2018-06, Vol.2 (12), p.1459-1469

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(390)
Mit Volltextzugriff
(457)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(288)
Life Sciences & Biomedicine
(196)
Humans
(173)
Female
(96)
Male
(86)
Technology
(67)
Middle Aged
(59)
Aged
(52)
Computer Science
(52)
Computer Science, Theory & Methods
(51)
Adult
(50)
Computer Science, Information Systems
(46)
Telecommunications
(46)
Networking And Internet Architecture
(45)
Cell Biology
(36)
Physical Sciences
(36)
Chemistry
(33)
Oncology
(32)
Risk Factors
(31)
Biological And Medical Sciences
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Membrane transport of cobalamin

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

Design and Application of Project-Based Learning Methodologies for Small Groups Within Computer Fundamentals Subjects

P618: SECOND‐GENERATION CD19 TARGETING TRI‐SPECIFIC KILLER ENGAGER DRIVES ROBUST NK CELL FUNCTION AGAINST B CELL MALIGNANCIES

Transcutaneous oxygen tension measurements following peripheral transluminal angioplasty procedure has more specificity and sensitivity than ankle brachial index

Cobalamin decyanation by the membrane transporter BtuM

Combination therapy with IL-15 superagonist (ALT-803) and PD-1 blockade enhances human NK cell immunotherapy against ovarian cancer

Using Genetic Engineering to Improve the Bispecific Antibody Platform for MDS Therapy

Development of Emotional Skills through Interdisciplinary Practices Integrated into a University Curriculum

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy

CONCEPTUALIZACIÓN DE ENTIDADES TERMINOLÓGICAS EN UNA SUBONTOLOGÍA DE DERECHO PENAL: ANÁLISIS DEL CONCEPTO SUPERORDINADO +DRUG_00 EN FUNGRAMKB

ARID5B regulates metabolic programming in human adaptive NK cells

965MO GTB-3550 tri-specific killer engager safely activates and delivers IL-15 to NK cells, but not T-cells, in immune suppressed patients with advanced myeloid malignancies, a novel paradigm exportable to solid tumors expressing Her2 or B7H3

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Intraperitoneal or subcutaneously administered IL-15 superagonist (N-803) increases NK cell cytotoxicity in ovarian cancer

755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cells

17P Driving NK cell immunotherapy against NSCLC, in the context of hypoxia, using tri-specific engagers

A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses

Cytokine-induced memory-like natural killer cells demonstrate enhanced effector functions against ovarian cancer

126P Novel B7-H3 targeting dual nanobody NK cell engagers display robust activity against a broad spectrum of solid and hematologic malignancies

Phase 1 trial of Ruxolitinib combined with Nivolumab in patients relapsed/refractory Hodgkin lymphoma after failure of check‐point inhibitor (CPI)

Responses after Allogeneic NK Cell Therapy for Lymphoma: correlative analysis revealed impact of host monocytes and robust T cells tumor trafficking

Cytomegalovirus and systemic inflammation is associated with worse outcomes in serous ovarian cancer patients

Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

Suchergebnisse filtern